T cell receptor-γ gene analysis of CD30+ large atypical individual cells in CD30+ large primary cutaneous T cell lymphomas

Journal of Investigative Dermatology

Volumn 120, Issue 4, 2003, Pages 670-675

  Gellrich, Sylke ^a,b   Wilks, Anke ^a   Lukowsky, Ansgar ^a   Wernicke, Martin ^a   Müller, Astrid ^a   Muche, J Marcus ^a   Fischer, Tanja ^a   Jasch, Kim Christian ^a   Audring, Heike ^a   Sterry, Wolfram ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CD30+; Clonality; CTCL; Lymphoma; Single cell analysis

Indexed keywords

CD30 ANTIGEN; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CASE REPORT; CLONE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISEASE COURSE; FEMALE; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; T LYMPHOCYTE; TUMOR CELL;

EID: 0037377660     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12101.x     Document Type: Article

References (31)

1. Bagot M, Martinvallet D, Echchakir H, et al: Functional inhibitory receptors expressed by a cutaneous T cell lymphoma-specific cytolytic clonal T cell population. J Invest Dermatol 115:994-999, 2000
2. Bagot M, Nikolova M, Schirm-Chabanette F, et al: Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. Ann N Y Acad Sci 941:31-38, 2001
3. Bekkenk MW, Geelen FA, van-Voorst-Vader PC, et al: Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: A report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95:3653-3661, 2000
4. + cutaneous lymphoproliferations. Blood 91:4668-4676, 1998
5. Falini B, Pileri S, Pizzolo G, et al: CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85;1-14, 1995
6. + lymphoma. Clinico-pathological findings and outcome. Blood 93:2697-2706, 1999
7. Gellrich S, Lukowsky A, Schilling T, et al: Microanatomical compartment of clonal and reactive cells in mycosis fungoides: Molecular demonstration by single cell PCR of T cell receptor gene rearrangement. J Invest Dermatol 115:620-624, 2000
8. Gruss HJ, Duyster J, Herrmann F: Structural and biological features of the TNF receptor and TNF ligand superfamilies: Interactive signals in the pathobiology of Hodgkin's disease. Ann Oncol 7:19-26, 1996
9. Horie R, Watanabe T: CD30. Expression and function in health and disease. Semin Immunol 10:457-470, 1998
10. Knaus PI, Lindemann D, DeCoteau JF, et al: A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 16:3480-3489, 1996
11. Küppers R, Rajewsky K, Zhao M, et al: Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci USA 91:10962-10966, 1994
12. Küppers R, Hansmann ML, Rajewsky K: Micromanipulation and PCR analysis of single cell from tissue sections. In: Weir DM, Blackwell C, Herzberg LA (eds). Handbook of Experimental Immunology, 5th edn. Cambridge, MA: Blackwell Science, 1995
13. Levi E, Wang Z, Petrogiannis-Haliotis T, et al: Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: A possible mechanism for disease progression. J Invest Dermatol 115:1034-1040, 2000
14. Li G, Salhany KE, Rook AH, et al: The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation. J Cutan Pathol 24:403-408, 1997
15. Linnemann T, Wiesmuller KH, Gellrich S, et al: A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma. Am Oncol 11:95-99, 2000
16. Linnemann T, Tumenjargal S, Gellrich S, et al: Mimotopes for tumor-specific T lymphocytes in human cancer determined with combinatorial peptide libraries. Eur J Immunol 31:156-165, 2001
17. Maeuschen M, Rajewsky K, Brauninger A, et al: Rare occurrence of classical Hodgkin's disease as a T cell lymphoma. J-Exp Med 191:387-394, 2000
18. Mori M, Manuelli C, Pimpinelli N, et al: CD30-CD30 ligand interaction in primary cutaneous CD30(+) T-cell lymphomas. A clue to the pathophysiology of clinical regression. Blood 94:3077-3083, 1999
19. Muche JM, Lukowsky A, Asadullah K, et al: Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with cutaneous T-cell lymphoma. Blood 90:1636-1642, 1997
20. Schiemann WP, Pfeifer WM, Levi E, et al: A deletion m the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 15:2854-2861, 1999
21. Schwab U, Stein H, Gerdes J, et al: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65-67, 1982
22. Smith CA, Gruss HJ, Davis T, et al: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349-1360, 1993
23. Stein H, Mason DY, Gerdes J, et al: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848-858, 1985
24. Tilly H, Gaulard P, Lepage E, et al: Primary anaplastic large-cell lymphoma in adults: Clinical presentation, immunophenotype, and outcome. Blood 90:3727-3734, 1997
25. Tonnies H, Stumm M, Wegner RD, et al: Comparative genomic hybridization based strategy for the analysis of different chromosome imbalances detected in conventional cytogenetic diagnostics. Cytogenet Cell Genet 93:188-194, 2001
26. Tramor KJ, Brisco MJ, Wan JH, et al: Gene rearrangement m B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood 78:192-196, 1991
27. Volkenandt M, Burmer GC, Schadendorf D, et al: The polymerase chain reaction. Method and applications in dermatopathology. Am J Dermatopathol 15:118-126, 1993
28. Willemze R, Beljaards PC: Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28:973-980, 1993
29. Willemze R, Meijer CJ: EORTC classification for primary cutaneous lymphomas: a comparison with the R.E.A.L. Classification and the proposed WHO Classification. Ann Oncol 11:11-15, 2000
30. Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354-371, 1997
31. Zoi Toli O, Vermeer MH, De-Vries E, et al: Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): Association between lack of Fas expression and aggressive types of CTCL. Br J Dermatol 143:313-319, 2000